SS

Sameer Saheblal Sayyed

Active Director Director DIN 10896740
DIN 10896740 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sameer Saheblal Sayyed

Data last updated:

Sameer Saheblal Sayyed is a Director at Loremedy Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 10896740
Primary Designation Director
Industry Pharma
First Appointment 04 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jan 20252025Active

Board colleagues of Sameer Saheblal Sayyed

NameDINCompanyDesignation
Abdul Hadi Shaikh10896741Loremedy Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Loremedy Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sameer Saheblal Sayyed

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sameer Saheblal Sayyed

Sameer Saheblal Sayyed currently holds 1 directorship: Loremedy Pharmaceuticals Private Limited (Director, since 04 Jan 2025).

Sameer Saheblal Sayyed was first appointed on 04 Jan 2025 as Director at Loremedy Pharmaceuticals Private Limited.

The current boards of Sameer Saheblal Sayyed's companies include Abdul Hadi Shaikh (Loremedy Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available